Posts in: December, 2017

340B Legislation Introduced

On Thursday, December 21st, Rep. Larry Bucshon (R-IN) and Rep. Scott Peters (D-CA) introduced the 340B PAUSE Act, H.R. 4710, in the U.S. House of

22 Dec

Update on 340B Ceiling Price and Manufacturer Civil Monetary Penalties

The White House Office of Management and Budget (OMB) has posted an abstract of HRSA’s new proposed rule on 340B Ceiling Price and Manufacturer Civil

19 Dec

Ryan White Clinics in 340B Program Call for Constructive Dialogue

Washington, D.C. — “For over two decades, the 340B drug pricing program has been a cornerstone of Ryan White providers’ efforts to fight the HIV/AIDS

8 Dec

NIH Director Says March-In Rights Cannot Be Used to Lower Drug Prices

National Institutes of Health (NIH) Director Francis Collins stated yesterday that the agency does not have the authority to use its “march-in” rights as a

1 Dec
Top